- In March 2024, PhotoPharmics announced the launch of the largest-ever phototherapy clinical trial for Parkinson’s disease, aiming to evaluate its innovative light-based therapy as a non-invasive treatment option. The trial represents a major milestone in the use of phototherapy beyond dermatological and neonatal applications, potentially expanding its role into neurological disease management
